Erbitux - 07-09-2005 11:57 AM
Hi my name is Barry.
I was diagnosed with stage 4 SCC two weeks ago. Since then I have had two consults [at Johns Hopkins and Sloan Kettering] and have done a lot of reading. Both consults recommended chemoradiation treatment. I will be meeting with both a medical and radiation oncologists at Johns Hopkins this coming tuesday.
While doing my research, I read a 6/7/04 news release that indicated a new drug [Erbitux] "in conjunction with radiation nearly doubles the survival time compared with patients treated just with radiation with relatively minor side effects". Sounds almost too good to be true!
The news release indicated that this drug was in a phase 3 trial and FDA was expected to review these trials in late 2004 and if approved the drug would be available for patients in spring/ summenr, 2005.
My questions are [1] has anyone participated in the trial and what has been their experience including side-effects and [2] does anyone have any updated information on FDA approval.
Thanks
Barry
I was diagnosed with stage 4 SCC two weeks ago. Since then I have had two consults [at Johns Hopkins and Sloan Kettering] and have done a lot of reading. Both consults recommended chemoradiation treatment. I will be meeting with both a medical and radiation oncologists at Johns Hopkins this coming tuesday.
While doing my research, I read a 6/7/04 news release that indicated a new drug [Erbitux] "in conjunction with radiation nearly doubles the survival time compared with patients treated just with radiation with relatively minor side effects". Sounds almost too good to be true!
The news release indicated that this drug was in a phase 3 trial and FDA was expected to review these trials in late 2004 and if approved the drug would be available for patients in spring/ summenr, 2005.
My questions are [1] has anyone participated in the trial and what has been their experience including side-effects and [2] does anyone have any updated information on FDA approval.
Thanks
Barry